Navigation Links
MiMedx Group, Inc. Announces Release Date for Second Quarter Results
Date:7/22/2011

MARIETTA, Ga., July 22, 2011 /PRNewswire/ -- MiMedx Group, Inc. (OTCBB: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterial-based products and bioimplants processed from human amniotic membrane, announced today that its results for the second quarter, ended June 30, 2011, will be released before the opening of the market on Monday, July 25, 2011. MiMedx will host a live broadcast of its second quarter conference call on July 25, 2011, beginning at 10:30 a.m. Eastern Time. A listen-only simulcast of the MiMedx Group conference call will be available online at the Company's website at www.mimedx.com or at www.earnings.com. A 30-day online replay will be available approximately one hour following the conclusion of the live broadcast. The replay can also be found on the Company's website at www.mimedx.com or www.earnings.com.

About the Company

MiMedx® is an integrated developer, manufacturer and marketer of patent protected regenerative biomaterial products and bioimplants processed from human amniotic membrane.  "Innovations in Regenerative Biomaterials" is the framework behind our mission to give physicians products and tissues to help the body heal itself. Our biomaterial platform technologies include the device technologies HydroFix™ and CollaFix™, and our tissue technologies, AmnioFix™ and EpiFix®. Our tissue technologies, processed from the human amniotic membrane, utilize our proprietary Purion® process that was developed by our wholly-owned subsidiary, Surgical Biologics, to produce a safe, effective and minimally manipulated implant. Surgical Biologics is the leading supplier of amniotic tissue, having supplied over 35,000 implants to date to distributors and OEMs for application in the Oph
'/>"/>

SOURCE MiMedx, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. MiMedx Group Completes $5,000,000 Private Placement
2. MiMedx Group, Inc. to Present at the Noble Financial Capital Markets Seventh Annual Equity Conference
3. MiMedx Group Announces First Quarter 2011 Results
4. MiMedx Group Announces 2010 Results
5. MiMedx Group, Inc. to Present at the 10th Annual Needham Healthcare Conference
6. MiMedx Announces Launch of AmnioFix™
7. MiMedx to Attend American Academy of Orthopedic Surgeons Annual Meeting
8. MiMedx Group, Inc. to Present at the 13th Annual Needham Growth Conference
9. MiMedx Group, Inc. Announces Release Date For Third Quarter Results
10. MiMedx Group, Inc. to Present at Noble Financial Sixth Annual Equity Conference
11. MiMedx Group Announces Temporary Trading Symbol Designation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... Over the last decade, the laboratory filtration ... budgets and increased acceptance of new filtration technologies in ... industries are also catalyzing the growth of laboratory filtration ... to grow at a strong CAGR during the forecast ... $2,532.6 million by 2019. The market is mainly driven ...
(Date:9/30/2014)... 30, 2014 Follow us on ... each type of cholesterol carrier or lipoprotein in the ... excessive cholesterol levels in the body, especially along the ... heart attack and other cardiovascular disorders. Cardiovascular Diseases (CVD) ... for cholesterol levels on a regular basis, to assess ...
(Date:9/30/2014)... 2014 CORD:USE Cord Blood Bank – ... has entered into an Equity and Exclusive Services Agreement ... series of patented technologies for the isolation of human ... Tianhe is performing Phase I/II clinical trials in ... using Tianhe,s Stem Cell Educator Therapy showing that ...
(Date:9/30/2014)... Genedata, a leading provider ... and related life science research, today announced ... Selector as its host-pathogen data analysis platform ... a European consortium dedicated to improving the ... anti-fungal drug therapies. Genedata Selector supports this ...
Breaking Biology Technology:Global Laboratory Filtration Market To See 7.0% CAGR to 2019 Says a Research Report Available at ReportsnReports.com 2Global Laboratory Filtration Market To See 7.0% CAGR to 2019 Says a Research Report Available at ReportsnReports.com 3Global Laboratory Filtration Market To See 7.0% CAGR to 2019 Says a Research Report Available at ReportsnReports.com 4Global Laboratory Filtration Market To See 7.0% CAGR to 2019 Says a Research Report Available at ReportsnReports.com 5Surging Diabetic, Obese and Hypertensive Population Drives the Global Cholesterol Testing Market, According to New Report by Global Industry Analysts, Inc. 2Surging Diabetic, Obese and Hypertensive Population Drives the Global Cholesterol Testing Market, According to New Report by Global Industry Analysts, Inc. 3Surging Diabetic, Obese and Hypertensive Population Drives the Global Cholesterol Testing Market, According to New Report by Global Industry Analysts, Inc. 4CORD:USE is Pleased to Announce it has Partnered with Tianhe Stem Cell Biotechnologies, Developer of Cord Blood Stem Cell Therapy Showing Promising Results in Clinical Trials for the Treatment of Diabetes and Autoimmune Diseases 2CORD:USE is Pleased to Announce it has Partnered with Tianhe Stem Cell Biotechnologies, Developer of Cord Blood Stem Cell Therapy Showing Promising Results in Clinical Trials for the Treatment of Diabetes and Autoimmune Diseases 3CORD:USE is Pleased to Announce it has Partnered with Tianhe Stem Cell Biotechnologies, Developer of Cord Blood Stem Cell Therapy Showing Promising Results in Clinical Trials for the Treatment of Diabetes and Autoimmune Diseases 4FUNGITECT Consortium Adopts Genedata Selector as Data Analysis Platform for Anti-fungal R 2FUNGITECT Consortium Adopts Genedata Selector as Data Analysis Platform for Anti-fungal R 3
... HILLS, Mass., Sept. 22 Joseph F. Finn, Jr.,C.P.A. ... for,the benefit of creditors, announced today that all oral ... bid auction on October 10,2008., The three ... Delivery System 2. Biological Factors Affecting the Bioadhesion ...
... million received based on the positive review of interim ... EDMONTON, Sept. 22 /PRNewswire-FirstCall/ - BioMS Medical Corp. ... sclerosis (MS), today,announced that it has received the US$10 ... The milestone payment is based on the previously ...
... and Delivery Enable CyberKnife Centers ... Fulfill Increasing Demand for Radiosurgery, SUNNYVALE, Calif., Sept. ... leader in the field of radiosurgery,announced today that Oklahoma ... has dramatically reduced treatment,planning and delivery times over the ...
Cached Biology Technology:Spherics, Inc. Presented Three Key Technologies (BIOROD(TM), BIOGIT(TM), and SPHEROMER(TM)) at the 35th Annual Meeting of Controlled Release Society 2BioMS Medical announces receipt of milestone payment from Eli Lilly and Company 2Oklahoma CyberKnife Center Cuts Treatment Time in Half With Next Generation CyberKnife Technology 2Oklahoma CyberKnife Center Cuts Treatment Time in Half With Next Generation CyberKnife Technology 3Oklahoma CyberKnife Center Cuts Treatment Time in Half With Next Generation CyberKnife Technology 4
(Date:9/30/2014)... , Sept. 30, 2014  Spectra Automation, ... for the biotech and power generation industries, ... RECONN Bioprocess Manager, an easy-to-use and cost-effective ... towards bioprocess development laboratories. ... bioreactor and analyzer systems. Accessing and consolidating ...
(Date:9/30/2014)... KONG , Sept. 30, 2014 Winners of ... Economist Events, Innovation Summit scheduled to take place at the JW ... the summit, the award winners will share their experiences and the ... who have made a proven innovation over the past decade, will ... the night before the summit. It will be the first ...
(Date:9/29/2014)... September 29, 2014 -- Plants have a symbiotic ... the pants extract nutrients and defend against invaders ... contaminating fruits and vegetables. Now, scientist have discovered ... of seeds; thus ensuring that sprouting plants are ... University of Notre Dame, presented their findings today ...
Breaking Biology News(10 mins):Spectra Automation Introduces RECONN Bioprocess Manager 2Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 2Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 3Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 4Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 5Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 6Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 7Plants prepackage beneficial microbes in their seeds 2
... STOCKHOLM, Sweden: The last six years have seen significant ... food to children, with an increasing number of governments ... leading expert on the topic said today (Tuesday). ... Tim Lobstein presented an analysis of the European policy ...
... University effort to develop aviation bio-fuel is underway with ... Aviation Fuels Northwest" project; the first of its kind ... Boeing, the Port of Seattle, The Port of Portland, ... biomass options within a four-state region as possible sources ...
... patients may soon have the option of custom-made ... thanks to researchers at the University of Illinois ... Whether resulting from illness or injury, loss of ... cosmetic implications: The patient,s chewing, swallowing, speaking or ...
Cached Biology News:Progress made in addressing food marketing to children, but challenges remain 2Progress made in addressing food marketing to children, but challenges remain 3Progress made in addressing food marketing to children, but challenges remain 4First of its kind: WSU led Bio-Jet fuel project officially gets off the ground 2Engineering could give reconstructive surgery a facelift 2